Alpay Düşgün

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score.

|Jun 26, 2026
Enzalutamide Versus Abiraterone After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Real-World Outcomes and Exploratory Prognostic Stratification.

|Sep 27, 2025
Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy.

Pinar Peker, Asli Geçgel, Oğuzcan Özkan

|Jun 13, 2025
Prognostic Power of the Naples Score in Non-Small Cell Lung Cancer: Can Inflammation and Nutrition Predict Survival?

Pınar Peker, Aslı Geçgel, Alpay Düşgün

Pageof 1

Frequent Collaborators

2 joint publications

Pınar Peker

2 joint publications

Aslı Geçgel

2 joint publications

Oğuzcan Özkan

2 joint publications

Mert Tohumcuoğlu